Caffo O, Frantellizzi V, Monari F, Galli L, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Donner D, Fanti S, Sbrana A, Morabito A, Masini C, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, De Giorgi U, Lo Re G, Cortesi E, De Vincentis G., Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra., «CANCER BIOTHERAPY & RADIOPHARMACEUTICALS», 2021, 36, pp. 391 - 396 [articolo]
Caffo O, Frantellizzi V, Monari F, Sbrana A, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Palermo A, Fanti S, Biasco E, Murabito A, Filice A, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, Cortesi E, Vincentis G., Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients., «FUTURE ONCOLOGY», 2021, 17, pp. 807 - 815 [articolo]
Zamagni E.; Nanni C.; Dozza L.; Carlier T.; Bailly C.; Tacchetti P.; Versari A.; Chauvie S.; Gallamini A.; Gamberi B.; Caillot D.; Patriarca F.; Macro M.; Boccadoro M.; Garderet L.; Barbato S.; Fanti S.; Perrot A.; Gay F.; Sonneveld P.; Karlin L.; Cavo M.; Bodet-Milin C.; Moreau P.; Kraeber-Bodere F., Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma, «JOURNAL OF CLINICAL ONCOLOGY», 2021, 39, pp. 116 - 125 [articolo]
Serenari M.; Bonatti C.; Zanoni L.; Peta G.; Tabacchi E.; Cucchetti A.; Ravaioli M.; Pettinato C.; Bagni A.; Siniscalchi A.; D'Errico A.; Golfieri R.; Fanti S.; Cescon M., The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study, «UPDATES IN SURGERY», 2021, 73, pp. 197 - 208 [articolo]Open Access
Abrams-Pompe RS, Fanti S, Schoots IG, Moore CM, Turkbey B, Vickers AJ, Walz J, Steuber T, Eastham JA., The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature., «EUROPEAN UROLOGY ONCOLOGY», 2021, 4, pp. 370 - 395 [articolo]
Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schiavina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S., The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis., «CANCERS», 2021, 13, Article number: 1575, pp. 1 - 24 [articolo]Open Access
Zanoni L.; Mei R.; Bianchi L.; Giunchi F.; Maltoni L.; Pultrone C.V.; Nanni C.; Bossert I.; Matti A.; Schiavina R.; Fiorentino M.; Fonti C.; Lodi F.; D'errico A.; Brunocilla E.; Fanti S., The role of [18f]fluciclovine PET/CT in the characterization of high-risk primary prostate cancer: Comparison with [11c]choline PET/CT and histopathological analysis, «CANCERS», 2021, 13, Article number: 1575, pp. 1575 - 1598 [articolo]Open Access
Zanoni L.; Bianchi L.; Nanni C.; Pultrone C.; Giunchi F.; Bossert I.; Matti A.; Schiavina R.; Fiorentino M.; Romagnoli D.; Fonti C.; Lodi F.; D'Errico A.; Brunocilla E.; Porreca A.; Fanti S., [18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 49, pp. 390 - 409 [articolo]
Argalia, Giulia; Malavasi, Silvia; Fortunati, Emilia; Calabrò, Diletta; Campana, Davide; Casadei, Riccardo; Ricci, Claudio; Bevilacqua, Alessandro; Fanti, Stefano; Ambrosini, Valentina, [68Ga]Ga-DOTANOC PET/CT Derived Radiomic Features Can Discriminate Pancreatic Neuroendocrine Tumours from Accessory Spleens: Preliminary Results, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. 142 - 142 [abstract]
Calabrò, Diletta; Bevilacqua, Alessandro; Malavasi, Silvia; Baiocco, Serena; Ricci, Claudio; Casadei, Riccardo; Campana, Davide; Fanti, Stefano; Ambrosini, Valentina, [68Ga]Ga-DOTANOC PETICT & radiomics: Potential role in discriminating tumor grade in well-differentiated primary pancreatic neuroendocrine tumors, «JOURNAL OF NEUROENDOCRINOLOGY», 2021, 33, pp. 177 - 177 [abstract]
Matushita CS, da Silva AMM, Schuck PN, Bardisserotto M, Piant DB, Pereira JL, Cerci JJ, Coura-Filho GB, Esteves FP, Amorim BJ, Gomes GV, Brito AET, Bernardo WM, Mundstock E, Fanti S, Macedo B, Roman DH, Tem-Pass CS, Hochhegger B., 68Ga-Prostate-specific membrane antigen (psma) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis., «INTERNATIONAL BRAZ J UROL», 2021, 47, pp. 705 - 729 [articolo]Open Access
Serenari, Matteo; Calabrò, Diletta; Bonfiglioli, Rachele; Fanti, Stefano; Ravaioli, Matteo, 99mTc-Mebrofenin Hepatobiliary Scintigraphy Combined With SPECT/CT to Assess Liver Function in Heterotopic Segmental Liver Transplantation in the Splenic Fossa, «CLINICAL NUCLEAR MEDICINE», 2021, 46, pp. E332 - E335 [abstract]
Telo S, Calderoni L, Vichi S, Zagni F, Castellucci P, Fanti S., Alternative and New Radiopharmaceutical Agents for Lung Cancer., «CURRENT RADIOPHARMACEUTICALS», 2020, 13, pp. 185 - 194 [articolo]
Moris L, Cumberbatch MG, Van den Broeck T, Gandaglia G, Fossati N, Kelly B, Pal R, Briers E, Cornford P, De Santis M, Fanti S, Gillessen S, Grummet JP, Henry AM, Lam TBL, Lardas M, Liew M, Mason MD, Omar MI, Rouvière O, Schoots IG, Tilki D, van den Bergh RCN, van Der Kwast TH, van Der Poel HG, Willemse PM, Yuan CY, Konety B, Dorff T, Jain S, Mottet N, Wiegel T., Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review., «EUROPEAN UROLOGY», 2020, 77, pp. 614 - 627 [articolo]
Van den Broeck, T; van den Bergh, Rcn; Briers, E; Cornford, P; Cumberbatch, M; Tilki, D; De Santis, M; Fanti, S; Fossati, N; Gillessen, S; Grummet, Jp; Henry, Am; Lardas, M; Liew, M; Mason, M; Moris, L; Schoots, Ig; van der Kwast, T; van der Poel, H; Wiegel, T; Willemse, Pm; Rouvière, O; Lam, Tb; Mottet, N., Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations., «EUROPEAN UROLOGY FOCUS», 2020, 6, pp. 231 - 234 [articolo]
